Back
Aldeyra Therapeutics 10K Form
Sell
40
ALDX
Aldeyra Therapeutics
Last Price:
$4.87
Seasonality Move:
3.92%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive ALDX News And Ratings
See the #1 stock for the next 7 days that we like better than ALDX
ALDX Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $-8M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $1.43 |
| Price / Book: | 3.4 |
Profitability
| EPS (TTM): | -0.75000 |
|---|---|
| Net Income (TTM): | $-44.8M |
| Gross Margin: | $0 |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Aldeyra Therapeutics Earnings Forecast
Key Aldeyra Therapeutics Financial Ratios
-
The Interest Expense is -5.52% of Operating Income.
-
Per Share Earnings over the last 13 years have been positive in 8 years.
Aldeyra Therapeutics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | ALDX |
| CUSIP: | 01438T |
| Website: | aldeyra.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
ALDX Technical Analysis vs Fundamental Analysis
Sell
40
Aldeyra Therapeutics (ALDX)
is a Sell
Is Aldeyra Therapeutics a Buy or a Sell?
-
Aldeyra Therapeutics stock is rated a SellThe current Aldeyra Therapeutics [ALDX] share price is $4.86. The Score for ALDX is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.